4D Molecular Therapeutics (FDMT) P/E (2020 - 2026)
4D Molecular Therapeutics (FDMT) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM 4D Molecular Therapeutics (FDMT) P/E is -3.38. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of 4D Molecular Therapeutics (FDMT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.38 | +39.05% |
| 2025 | -2.43 | +41.15% |
| 2024 | -1.72 | -77.50% |
| 2023 | -7.65 | +12.18% |
| 2022 | -6.82 | -22.45% |
| 2021 | -8.80 | -83.65% |
| 2020 | -53.82 | N/A |
Comparison 4D Molecular Therapeutics (FDMT) P/E with competitors
4D Molecular Therapeutics (FDMT) P/E is -3.38.